Rapid Micro Biosystems
RPID
52 hedge funds and large institutions have $112M invested in Rapid Micro Biosystems in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 8 increasing their positions, 16 reducing their positions, and 21 closing their positions.
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
1.48% less ownership
Funds ownership: 73.23% → 71.75% (-1.5%)
12% less funds holding
Funds holding: 59 → 52 (-7)
24% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 21
38% less capital invested
Capital invested by funds: $181M → $112M (-$68.8M)
50% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KLM
Kennedy Lewis Management
New York
|
+$14.3M |
| 2 |
IV
Industry Ventures
San Francisco,
California
|
+$1.34M |
| 3 |
AI
Arena Investors
Purchase,
New York
|
+$1.09M |
| 4 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
+$873K |
| 5 |
Millennium Management
New York
|
+$508K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCP
D1 Capital Partners
New York
|
-$18M |
| 2 |
BlackRock
New York
|
-$2.76M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.84M |
| 4 |
PA
Perceptive Advisors
New York
|
-$1.29M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.29M |
RPID Hedge Fund Activity: Q2 2022 in Review
52 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Rapid Micro Biosystems (RPID) for Q2 2022, worth a combined $112M — down 38% from $181M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of RPID and 16 opened new positions — a net loss of 5 holders — while 16 trimmed existing stakes and 8 added.
The largest buyer was Kennedy Lewis Management, adding an estimated $14.3M. The largest seller was D1 Capital Partners, exiting entirely with an estimated $18M sold.
- 52 institutional investors held Rapid Micro Biosystems (RPID) as of Q2 2022, down from 59 in Q1 2022.
- Funds reported $112M of Rapid Micro Biosystems stock for Q2 2022, down 38% quarter-over-quarter.
- 16 funds opened new Rapid Micro Biosystems positions in Q2 2022 and 21 closed out, a net change of -5 holders.
- The largest Rapid Micro Biosystems buyer in Q2 2022 was Kennedy Lewis Management, an estimated $14.3M added.
- The largest Rapid Micro Biosystems seller in Q2 2022 was D1 Capital Partners, an estimated $18M sold.
Based on aggregated 13F filings for Q2 2022.